Search for a clinical trial
Other search option(s)
13 Result(s)
Recruiting trial
= ; Ongoing trial
=
; Terminated trial =
; Funded by an IRDiRC member =
; Member of a ERN =
National clinical trial(s)

FRANCE
ILE-DE-FRANCE
PARIS

FancoMob : Pilot Study Assessing the Feasibility of CD34+ Cells Mobilization and Collection After Treatment With G-CSF and Plerixafor in Patients With Fanconi Anemia for Subsequent Treatment by Gene Therapy (Phase I-II)
Hôpital Necker-Enfants Malades
Service d'Hématologie adulte

ITALY
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
Follow-up of phase I/II study of CaspaCide T cells from an HLA-partially matched family donor after negative selection of TCR alfa-beta+ T cells in pediatric patients affected by hematological disorders - IT
Institution: Information not provided - IT

SPAIN
Madrid
ADDRESS: NOT PROVIDED - ES

FANCOLEN-II: A Phase II Clinical Trial to Evaluate the Efficacy of the Infusion of Autologous CD34+ Cells Transduced with a Lentiviral Vector Carrying the FANCA Gene (Orphan Drug) in Patients with Fanconi Anemia Subtype A -ES
Institution: Information not provided - ES

SPAIN
Madrid
ADDRESS: NOT PROVIDED - ES

Long-Term Follow-up: Phase I/II clinical study to evaluate the safety and efficacy of the infusion of autologous CD34+ cells transduced with a lentiviral vector carrying the FANCA gene (orphan drug) in patients with Fanconi Anaemia Subtype A - ES
Institution: Information not provided - ES

SPAIN
Madrid
MADRID

An open clinical trial, phase II to evaluate the efficacy and safety of the use of eltrombopag in children and adolescents with Fanconi Anemia - ES
Hospital Infantil Universitario Niño Jesús
Servicio de Hematología y Hemoterapia

UNITED KINGDOM
Greater London
LONDON
Follow-up of Phase 1/2 Study of CaspaCIDe T Cells (BPX-501) From an HLA-partially Matched Family Donor After Negative Selection of TCR α β+T Cells in Pediatric Patients Affected by Hematological Disorders-GB
GOSH NHS Foundatin Trust
Great Ormond Street Hospital

UNITED STATES
Ohio
CINCINNATI


Quercetin in Children With Fanconi Anemia; a Pilot Study (Phase 1) - US
Cincinnati Children's Hospital Medical Center
Department of Pediatry

FRANCE
ILE-DE-FRANCE
PARIS

RACE : A Prospective Randomized Multicenter Study Comparing Horse Antithymocyte Globuline (hATG) + Cyclosporine A (CsA) With or Without Eltrombopag as Front-line Therapy for Severe Aplastic Anemia Patients (Phase III) - FR
GHU AP-HP Nord. Université de Paris - Hôpital Saint-Louis
Service d'Hématologie-Greffe

GERMANY
Baden-Württemberg
ULM

EMAA: Efficacy and Safety of Eltrombopag in Patients with Acquired Moderate Aplastic Anemia who are treated with Ciclosporin A (Phase II/III) - DE
DRK Baden-Württemberg/ Hessen
Institut für Klinische Transfusionsmedizin und Immungenetik Ulm

ITALY
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
RACE: A Prospective Randomized Multicenter Study Comparing Horse Antithymocyte Globuline (hATG) + Cyclosporine A (CsA) With or Without Eltrombopag as Front-line Therapy for Severe Aplastic Anemia Patients - IT
Institution: Information not provided - IT

UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US


Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Institution: Information not provided - US
Multinational clinical trial(s)

UNITED STATES
Texas
HOUSTON
Follow-up of Phase 1/2 Study of CaspaCIDe T Cells (BPX-501) From an HLA-partially Matched Family Donor After Negative Selection of TCR α β+T Cells in Pediatric Patients Affected by Hematological Disorders
Bellicum Pharmaceuticals, Inc.

UNITED KINGDOM
Greater London
ADDRESS: NOT PROVIDED - GB